IONS vs SLRC · rev $514.0M vs P/E 10, $892.5M cap
Ionis Pharmaceuticals Inc (IONS) versus SLR Investment Corp (SLRC) — a side-by-side from cached financials, not a winner call.
Ionis Pharmaceuticals Inc (IONS) is a biotechnology company listed on NASDAQ.
SLR Investment Corp (SLRC) is a asset management company listed on US.
Latest reported IONS revenue for 2026-06-30 was $514.0M. Net income was -$207.2M. IONS currently screens at market cap $12.28B.
SLRC does not have a complete income-statement cache yet.
IONS currently screens at market cap $12.28B. SLRC currently screens at market cap $892.5M and trailing P/E 10.1.
Not investment advice. Open the IONS and SLRC stock pages for the full models.
Not investment advice.